Registro:

Referencias:

• Aggarwal, B.B., Sundaram, C., Malani, N., Ichikawa, H., Curcumin: The Indian solid gold (2007) Advances in Experimental Medicine and Biology, 595, pp. 1-75
• Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: Problems and promises (2007) Molecular Pharmacology, 4, pp. 807-818
• Barnes, P.J., Role of HDAC2 in the pathophysiology of COPD (2008) Annual Reviews in Physiology, 71, pp. 451-464
• Bilodeau, S., Vallette-Kasic, S., Gauthier, Y., Figarella-Branger, D., Brue, T., Berthelet, F., Lacroix, A., Drouin, J., Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease (2006) Genes and Development, 20 (20), pp. 2871-2886. , http://www.genesdev.org/cgi/reprint/20/20/2871, DOI 10.1101/gad.1444606
• Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): A novel strategy for human cancer therapy (2007) Journal of Nanobiotechnology, 5, pp. 1-18
• Cao, J., Liu, Y., Jia, L., Zhou, H.-M., Kong, Y., Yang, G., Jiang, L.-P., Zhong, L.-F., Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells (2007) Free Radical Biology and Medicine, 43 (6), pp. 968-975. , DOI 10.1016/j.freeradbiomed.2007.06.006, PII S0891584907003917
• Carroll, C.E., Ellersieck, M.R., Hyder, S.M., Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells (2008) Menopause, 15, pp. 570-574
• Chadalapaka, G., Jutooru, I., Chintharlapalli, S., Papineni, S., Smith III, R., Li, X., Safe, S., Curcumin decreases specificity protein expression in bladder cancer cells (2008) Cancer Research, 68, pp. 5345-5354
• Chanson, P., Salenave, S., Acromegaly (2008) Orphanet Journal of Rare Diseases, 3, p. 17
• Corson, T.W., Crews, C.M., Molecular understanding and modern application of traditional medicines: Triumphs and trials (2007) Cell, 130, pp. 769-774
• Davis, J.R., Farrell, W.E., Clayton, R.N., Pituitary tumours (2001) Reproduction, 121, pp. 363-371
• Dhillon, N., Aggarwal, B.B., Newman, R.A., Wolff, R.A., Kunnumakkara, A.B., Abbruzzese, J.L., Ng, C.S., Kurzrock, R., Phase II trial of curcumin in patients with advanced pancreatic cancer (2008) Clinical Cancer Research, 14, pp. 4491-4499
• Dujic, J., Kippenberger, S., Ramirez-Bosca, A., Diaz-Alperi, J., Bereiter-Hahn, J., Kaufmann, R., Bernd, A., Hofmann, M., Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model (2008) International Journal of Cancer, 124, pp. 1422-1428
• Ezzat, S., Asa, S.L., Mechanisms of disease: The pathogenesis of pituitary tumors (2006) Nature Clinical Practice. Endocrinology and Metabolism, 2, pp. 220-230
• Fitzpatrick, F.A., Wheeler, R., The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents (2003) International Immunopharmacology, 3 (13-14), pp. 1699-1714. , DOI 10.1016/j.intimp.2003.08.007
• Gidding, C.E., Kellie, S.J., Kamps, W.A., De Graaf, S.S., Vincristine revisited (1999) Critical Review in Oncology and Hematology, 29, pp. 267-287
• Hatcher, H., Planalp, R., Cho, J., Torti, F.M., Torti, S.V., Curcumin: From ancient medicine to current clinical trials (2008) Cellular and Molecular Life Sciences, 65, pp. 1631-1652
• Johnson, J.J., Mukhtar, H., Curcumin for chemoprevention of colon cancer (2007) Cancer Letters, 255, pp. 170-181
• Kunnumakkara, A.B., Anand, P., Aggarwal, B.B., Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins (2008) Cancer Letters, 269, pp. 199-225
• Mancini, T., Casanueva, F.F., Giustina, A., Hyperprolactinemia and prolactinomas (2008) Endocrinology and Metabolism Clinics of North America, 37, pp. 67-99
• Miller, M., Chen, S., Woodliff, J., Kansra, S., Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells (2008) Endocrinology, 149, pp. 4158-4167
• Newell-Price, J., Bertagna, X., Grossman, A.B., Nieman, L.K., Cushing's syndrome (2006) Lancet, 367, pp. 1605-1617
• Pae, H.O., Jeong, S.O., Kim, H.S., Kim, S.H., Song, Y.S., Kim, S.K., Chai, K.Y., Chung, H.T., Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits NO production, inducible NO synthase expression and NF-kB activation in RAW264.7 macrophages activated with LPS (2008) Molecular Nutrition & Food Research, 52, pp. 1082-1091
• Paez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A.C., Hopfner, U., Grubler, Y., Chervin, A., Arzt, E., Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) Proceedings of the National Academy of Sciences of the United States of America, 100 (3), pp. 1034-1039. , DOI 10.1073/pnas.0237312100
• Park, C., Kim, G.Y., Kim, G.D., Choi, B.T., Park, Y.M., Choi, Y.H., Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells (2006) Oncology Reports, 15, pp. 1225-1231
• Perez Castro, C., Giacomini, D., Carbia Nagashima, A., Onofri, C., Graciarena, M., Kobayashi, K., Paez-Pereda, M., Arzt, E., Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells (2003) Endocrinology, 144 (2), pp. 693-700. , DOI 10.1210/en.2002-220891
• Quinn, J., Fisher, P.W., Capocasale, R.J., Achuthanandam, R., Kam, M., Bugelski, P.J., Hrebien, L., A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow (2007) Cytometry Part a, 71 (8), pp. 612-624. , DOI 10.1002/cyto.a.20416
• Renner, U., Newton, C.J., Pagotto, U., Sauer, J., Arzt, E., Stalla, G.K., Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation (1995) Endocrinology, 136, pp. 3186-3193
• Renner, U., Arzberger, T., Pagotto, U., Leimgruber, S., Uhl, E., Muller, A., Lange, M., Stalla, G.K., Heterogenous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas (1998) Journal of Clinical Endocrinology and Metabolism, 83 (4), pp. 1368-1375. , DOI 10.1210/jc.83.4.1368
• Sa, G., Das, T., Anti cancer effects of curcumin: Cycle of life and death (2008) Cell Division, 3, p. 14
• Sandur, S.K., Ichikawa, H., Pandey, M.K., Kunnumakkara, A.B., Sung, B., Sethi, G., Aggarwal, B.B., Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane) (2007) Free Radical Biology and Medicine, 43 (4), pp. 568-580. , DOI 10.1016/j.freeradbiomed.2007.05.009, PII S0891584907003255
• Shankar, S., Ganapathy, S., Chen, Q., Srivastava, R.K., Curcumin sensitizes TRAIL-resistant xenografts: Molecular mechanisms of apoptosis, metastasis and angiogenesis (2008) Molecular Cancer, 7, p. 16. , DOI 10.1186/1476-4598-7-16
• Shishodia, S., Chaturvedi, M.M., Aggarwal, B.B., Role of curcumin in cancer therapy (2007) Current Problems in Cancer, 31, pp. 243-305
• Singh, S., From exotic spice to modern drug? (2007) Cell, 130, pp. 765-768
• Srivastava, R.K., Chen, Q., Siddiqui, I., Sarva, K., Shankar, S., Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1) (2007) Cell Cycle, 6, pp. 2953-2961
• Stalla, G.K., Stalla, J., Von Werder, K., Muller, O.A., Gerzer, R., Hollt, V., Jakobs, K.H., Nitroimidazole derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme (1989) Endocrinology, 125 (2), pp. 699-706

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------